Theravance Biopharma (TBPH) Total Non-Current Liabilities (2013 - 2026)
Theravance Biopharma (TBPH) reported Total Non-Current Liabilities of $179.82 million for Q2 2026, down 9.9% from $199.64 million a year earlier and down 0.9% from the prior quarter.
Powered by 
Analysis
Theravance Biopharma (TBPH) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends
At the end of FY2025, Theravance Biopharma posted Total Non-Current Liabilities of $188.53 million, up 6.7% from FY2024.
- Total Non-Current Liabilities has a five-year compound annual growth rate of -24.5% (FY2020 to FY2025).
- By year, Total Non-Current Liabilities came in at $176.73 million in FY2024 (+8.4%), $163.09 million in FY2023 (-0.5%), $163.94 million in FY2022 (-76.9%) and $711.21 million in FY2021 (-7.8%).
- The Q2 2026 figure ranks as the lowest quarterly Total Non-Current Liabilities since Q1 2025.
- Year over year, Total Non-Current Liabilities gained in seven of the last eight quarters, with growth averaging 6.7%.
- The high point for year-over-year Total Non-Current Liabilities in five years was Q2 2025 (growth of 22.1%); the low point was Q2 2023 (a decline of 77.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $181.48 million (Q1 2026), $188.53 million (Q4 2025) and $182.47 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - | 179.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 179.82 Mn |
| Mar 31, 2026 | 181.48 Mn |
| Dec 31, 2025 | 188.53 Mn |
| Sep 30, 2025 | 182.47 Mn |
| Jun 30, 2025 | 199.64 Mn |
| Mar 31, 2025 | 176.31 Mn |
| Dec 31, 2024 | 176.73 Mn |
| Sep 30, 2024 | 165.47 Mn |
| Jun 30, 2024 | 163.46 Mn |
| Mar 31, 2024 | 160.99 Mn |
| Dec 31, 2023 | 163.09 Mn |
| Sep 30, 2023 | 159.78 Mn |
| Jun 30, 2023 | 158.79 Mn |
| Mar 31, 2023 | 160.31 Mn |
| Dec 31, 2022 | 163.94 Mn |
| Sep 30, 2022 | 281.26 Mn |
| Jun 30, 2022 | 708.17 Mn |
| Mar 31, 2022 | 704.38 Mn |
| Dec 31, 2021 | 711.21 Mn |
| Sep 30, 2021 | 724.09 Mn |
API Access
Theravance Biopharma Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();